Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$0.97 - $1.42 $36,472 - $53,392
-37,600 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$1.1 - $1.74 $9,460 - $14,964
8,600 Added 29.66%
37,600 $52,000
Q4 2018

Feb 11, 2019

BUY
$1.0 - $6.12 $14,000 - $85,680
14,000 Added 93.33%
29,000 $31,000
Q3 2017

Nov 01, 2017

BUY
$6.73 - $8.74 $100,950 - $131,100
15,000
15,000 $131,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $56.6M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.